Transforming Chronic Condition Management and Patient Selfcare
White paper – Discover which business opportunities digital health solutions enable for pharmaceutical companies, starting from research and development, expanding to commercialisation through pre-launch, expansion, maturity and loss of exclusivity. This paper offers practical advice from industry experts from Roche, ViiV Healthcare, S3 Connected Health and Ypsomed on key enablers for successful digital health solutions, on building effective partnerships and on leveraging fully integrated digital health platforms.
People with chronic conditions spend 99 % of their time managing their condition independent from care teams. Digital health solutions offer a significant opportunity to support patients throughout their treatment journey, from diagnosis and onboarding to adopting prescribed regimens and behavioural changes.
This paper details pharmaceutical companies’ business opportunities from digital health solutions starting in research and development and extending across the commercialisation process, through pre-launch, expansion, maturity and loss of exclusivity. The paper offers practical advice from industry experts from Roche, ViiV Healthcare, S3 Connected Health and Ypsomed on:
- Building a strong digital health value proposition
- Identifying the core problem the digital solution needs to solve
- Leveraging existing fully integrated digital health solutions to solve additional use cases
- Building successful partnerships to profit from domain expertise and efficient processes
Stay tuned, stay informed
Subscribe to the Ypsomed Blog and join our journey to simpler and easier selfcare.
